BDBM50069614 (2R,3S)-2-(2-Biphenyl-4-yl-2-oxo-ethylsulfanylmethyl)-N*1*-hydroxy-3-isobutyl-N*4*-((S)-1-methylcarbamoyl-2-phenyl-ethyl)-succinamide::CHEMBL433197
SMILES: CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)[C@H](CSCC(=O)c1ccc(cc1)-c1ccccc1)C(=O)NO
InChI Key: InChIKey=SIRCLPRKMINOTL-ULNSLHSMSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Immunoglobulin epsilon Fc receptor (Homo sapiens (Human)) | BDBM50069614 ((2R,3S)-2-(2-Biphenyl-4-yl-2-oxo-ethylsulfanylmeth...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 380 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Inhibition against CD23 (IgE receptor) proteolysis in membranes derived from RPM18866 cells | Bioorg Med Chem Lett 8: 29-34 (1999) BindingDB Entry DOI: 10.7270/Q2TT4Q3W | |||||||||||
More data for this Ligand-Target Pair |